FertiCheck Woman

FertiCheck Woman is intended for women who want to conceive and wish to be helped optimising their fertility.


What is FertiCheck Woman?

Having a varied diet in order to benefit from sufficient (micro)nutrient intake is one of the key elements to optimising fertility in women, whether it be through processes related to hormonal cycles, ovulation, embryo implantation or the first weeks of pregnancy.

FertiCheck is aimed at women who wish to conceive and want to be accompanied in optimising their fertility.

What can be expected from the results of FertiCheck Woman?

FertiCheck Woman helps to establish whether your micronutrient status is favourable for pregnancy. It also checks the balance of the omega 6/omega 3 essential for fertilisation, embryo implantation and the early stages of development.

All this information will allow you to make an informed decision about changing your diet or taking vitamin supplements.

Who is FertiCheck Woman for?

This profile is intended for all women who want to become pregnant, and particularly for accompanying those taking or considering taking supplements:

  • before, in order to fulfill the needs identified;
  • during, in order to monitor its effectiveness; and,
  • afterwards, to check its benefits.


CRP Ultrasensitive, Magnesium, Zinc, Selenium, Copper, Vitamin A, Vitamin E, Homocysteine, Coenzyme Q10, Vitamin B9 (erythrocyte), Vitamin D, Ferritin, Free T3, Erythrocyte fatty acid status

More information on FertiCheck Woman

Why does FertiCheck Women include these parameters specifically?

FertiCheck Woman combines test parameters that are essential to optimising of female fertility, from gametogenesis to the early stages of embryogenesis. The results of the following assays can be found in FertiCheck Woman panel:

  • Ultra-sensitive CRP, an elevation of which reflects the existence of low-grade inflammation, which is always deleterious, especially in this context;
  • Magnesium, a cofactor in many enzymatic reactions and involved in the fundamental epigenetic processes at the different stages of cell multiplication that accompany the various stages of reproduction;
  • Vitamin D, which has multiple implications for cellular metabolism, the level of which, often deficient among the general population, can be easily corrected;
  • Ferritin, a reflection of the body’s iron reserves, a cofactor of hydroxylases, indispensable from the preconception phase, which requires sufficient energy reserves and an optimised metabolism;
  • Free T3, a biologically active form of thyroid hormones, the level of which depends closely on the conversion of free T4, itself conditioned by a sufficient quantity of other substances including, in particular, iron, zinc, vitamins A and D, which are present in this profile;
  • Trace elements copper, zinc and selenium, as well as vitamins A and E, players in anti-oxidant protection, necessary in dealing with the major oxidative stress that accompanies these early stages of pregnancy;
  • Homocysteine, a major player in the methylation processes essential for cellular metabolism, the level of wich may reflect a deficiency in vitamins B6, B9 or B12;
  • More particularly erythrocyte folates, which guarantee the circulating level of vitamin B9, essential in periconception and in preventing the risk of neural tube closure deficiency at the very beginning of pregnancy;
  • Coenzyme Q10, a fundamental antioxidant of the body and protector against free radical attacks;
  • Different fractions of the erythrocyte fatty acid profile, making it possible to assess the impact of lipid intake on the balance of polyunsaturated fatty acids (PUFA), a fundamental component of the sperm acrosome.

For further reading...

Poppe K, Velkeniers B. Thyroid disorders in infertile women. Ann Endocrinol (Paris). 2003;64(1):45-50.

Elizabeth H. Ruder, Oxidative stress and antioxidants: exposure and impact on female fertility, Human Reproduction Update, Volume 14, Issue 4, July-August 2008, Pages 345–357.

Margit Laanpere, Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability, Nutrition Reviews, Volume 68, Issue 2, 1 February 2010, Pages 99–113.

Ford JH, Tavendale R. Analysis of fatty acids in early mid-life in fertile women: Implications for reproductive decline and other chronic health problems. Am J Hum Biol. 2010;22(1):134-136.

  • I am a professional and would like to be contacted to find out more about Juvenalis

      This site is protected by reCAPTCHA, les règles de confidentialité and terms of service apply.